Viewing Study NCT00629967

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:28 AM
Ignite Modification Date: 2026-01-19 @ 1:30 PM
Study NCT ID: NCT00629967
Status: COMPLETED
Last Update Posted: 2008-03-06
First Post: 2008-02-26
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Hepatitis C View
None Genotype View
Keywords:

Keywords

Keyword Brief Keyword Text View
None chronic hepatitis C View
None genotype 1 View
None rapid virological response View
None sustained virological response View
None peginterferon View
None ribavirin View
None treatment duration View